Cite

Figure 1

Outline of the prospective cohort study
Outline of the prospective cohort study

Ventilatory support data presented as N (%) and mean ± SD

No ALI/ARDS (n = 464)ALI/ARDS (n = 15)P95%CI
Mode of MV of day 1
  CMV290 (63%)9 (60%)0.79
  SIMV150 (32%)6 (40%)
Mode of MV of day 2 (n = 426)
  CMV177 (42%)8/15 (53%)0.38
  SIMV173 (40%)7/15 (47%)
Maximal tidal volume (mL)
  Day 1504.6 ± 101.4441.2 ± 85.20.0211.3, 115.4
  Day 2494.6 ± 94.4483.7 ± 115.50.70–38.3, 60.0
Maximal tidal volume per kg of PBW
  Day 19.3 ± 2.07.7 ± 1 . 60.0030.6, 2.6
  Day 29.2 ± 1.98.5 ± 2 . 00.16–0.3, 1.6
Maximal PEEP level (cmH2O)
  Day 15.1 ± 1.35.5 ± 1 . 20.25–1.0, 0.3
  Day 25.3 ± 1.66.8 ± 2 . 00.008–2.3, -0.7

Comparison of data between ALI/ARDS and non-ALI/ARDS groups. Data presented as n (%), mean ± standard deviation, and median (interquartile range).

No ALI/ARDS (n = 464)ALI/ARDS (n = 15)P95% CI
Age64.6 ± 16.666.3 ± 17.70.69–10.3, 6.8
Sex: male251 (54%)12 (80%)0.060.08, 1.1
Weight (kg)60.4 ± 14.060.7 ± 13.90.94–7.5, 6.9
Height (cm)160.1 ± 7.9162.5 ± 10.30.25–6.5, 1.7
Body mass index23.5 ± 5.022.7 ± 3.30.54–1.6, 3.4
Ethnicity: Thai458 (99%)14 (93%)0.200.6, 48.4
ASA >2362 (78%)13 (87%)0.540.4, 8.2
Functional class >250 (11%)3 (20%)0.220.6, 7.6
Smoking27 (6%)1 (7%)0.600.1, 9.1
Medical history
  Cardiovascular250 (54%)9 (60%)0.790.5, 3.7
  Diabetes114 (25%)4 (27%)0.770.4, 3.6
  Cerebrovascular40 (9%)1 (7%)1.000.1, 5.9
  Vascular38 (8%)2 (13%)0.360.4, 7.9
  Respiratory38 (8%)0 (0%)0.62
  End-stage renal disease28 (6%)4 (27%)0.011.7, 18.9
APACHE II score13.6 ± 6.619.4 ± 8 . 80.001–9.2, -2.4
Type of SICU admission
  No surgery102 (28%)7 (47%)0.050.1, 0.9
  After surgery362 (78%)8 (53%)
  Emergency or unplanned admission318/444 (72%)12/14 (86%)0.370.5, 10.8
  Hb at SICU admission10.4 ± 2.19.9 ± 2 . 20.35–0.6, 1.7
  Albumin at SICU admission2.6 ± 0.72.2 ± 0 . 70.09–0.05, 0.7
  Sepsis at SICU admission158 (34%)9 (60%)0.051.0, 8.3
  Balance fluid at 24 h1,593 (538, 2,832)2,368 (1,450, 5,299)0.08
Total red blood cell count (mL)644 (344, 1,048)1,069 (729, 1,613)0.03
Total FFP (mL)939 (467, 1,461)2,344 (1,248, 4,865)0.06

Organ dysfunction and outcomes, data presented as n (%)

No ALI/ARDS (n = 464)ALI/ARDS (n = 15)P95% CI
ARF48 (10%)5 (33%)0.021.4, 13.2
Pneumonia42 (9%)6 (40%)0.0022.3, 19.7
Sepsis39 (8%)3 (20%)0.140.7, 10.0
Shock25 (5%)2 (13%)0.200.6, 12.6
GI bleeding21 (5%)0>0.999
Myocardial ischemia9 (2%)0>0.999
Outcomes
  Duration of MV (day)5 (3, 12)17 (6, 22)0.002–14.4, 2.8
  ICU LOS (day)7 (4, 13)20 (6, 28)0.01–13.7, 2.0
  Hospital LOS (day)26 (15, 49)22 (8, 39)0.30–16.1, 18.0
  30-day mortality99 (21%)7 (47%)0.031.1, 9.1
  Hospital mortality109 (24%)9 (60%)0.0031.7, 14.0
eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine